HomeADMA • NASDAQ
add
ADMA Biologics Inc
Previous close
$15.18
Day range
$14.55 - $15.63
Year range
$13.50 - $25.67
Market cap
3.71B USD
Avg Volume
2.42M
P/E ratio
18.37
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 139.16M | 18.39% |
Operating expense | 26.06M | 4.22% |
Net income | 49.38M | -55.87% |
Net profit margin | 35.48 | -62.73% |
Earnings per share | 0.22 | 58.60% |
EBITDA | 64.80M | 60.92% |
Effective tax rate | 19.83% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 87.63M | -15.04% |
Total assets | 624.24M | 27.74% |
Total liabilities | 146.92M | 5.20% |
Total equity | 477.32M | — |
Shares outstanding | 238.16M | — |
Price to book | 7.55 | — |
Return on assets | 26.30% | — |
Return on capital | 29.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 49.38M | -55.87% |
Cash from operations | 35.64M | -29.03% |
Cash from investing | -276.00K | 89.96% |
Cash from financing | -9.12M | 70.61% |
Net change in cash | 26.24M | 59.64% |
Free cash flow | -291.88K | -100.71% |
About
Founded
2004
Headquarters
Website
Employees
647
